Important step towards approval of enhanced glaucoma medication LUMIGAN® (bimatoprost ophthalmic solution) 0.01% in 27 countries within the European Union Amsterdam, The Netherlands, 23 October, 2009 – Allergan Ltd. announced today that the Committee for Medicinal Products for Human Use (CHMP) has recommended granting a Marketing Authorisation for a new version of LUMIGAN® (bimatoprost ophthalmic [...]